Electrophysiological Neuroimaging using sLORETA Comparing 100 Schizophrenia Patients to 48 Patients with Major...

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Dopamine D2 receptors are crucial in brain function and targeted by antipsychotics.
• Schizophrenia and depression involve complex neurochemical imbalances.
• Identifying reliable biomarkers is essential for drug development.

Purpose of the Study:

• To identify a surrogate biomarker for Dopamine D2 receptors.
• To compare EEG patterns in schizophrenia patients on atypical antipsychotics versus depressed patients on SSRIs.

Main Methods:

• Retrospective analysis of resting electroencephalograms (EEG).
• Spectral transformation using sLORETA and statistical non-parametric mapping (SnPM).
• Comparison of Global Field Power across frequency bands between patient groups.

Main Results:

• Higher delta frequency band oscillations in the Right Superior Frontal Gyrus in schizophrenia patients compared to depressed female patients.
• The observed difference was statistically significant (t=2.049, p=0.007).
• No significant findings in comparisons with the overall depressive cohort or male depressive patients.

Conclusions:

• The Superior Frontal Gyrus shows potential as a surrogate biomarker for Dopamine D2 receptor activity.
• Further investigation is warranted for preclinical and clinical neuropharmacology drug discovery.
• This biomarker may help in developing novel treatments for neuropsychiatric disorders.